Studies on human complement 4 binding protein
Studies on human complement 4 binding protein
批准号:
03670325
负责人:
OKAMURA Seiichi
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992
中文摘要
1.人C4-结合蛋白(C4 BP)的纯化和抗纯化C4 BP抗体的开发通过多个步骤从1.5L血浆中纯化人C4 BPalpha,所述多个步骤包括BaCl 2沉淀、内毒素吸附、超离心、乙醇/乙醚萃取、柱色谱(DE 52、S400和S300)。针对这种蛋白质的抗体在兔子和小鼠中产生。还开发了单克隆抗体(IgG)。2.人基因组C4 BP基因分析人基因组C4 BPalpha基因。该基因由12个外显子组成,跨度约40 kb。每个SCR由单个外显子编码,除了第二个SCR(SCR II),其由两个单独的外显子编码。对5'侧翼区进行测序,从推定的转录起始位点上游至380个碱基。几个可能的结合位点的转录因子进行了鉴定。3. C4 BP α的基因表达证实了C4 BP α在正常肝细胞和肝癌细胞系中的基因表达。C4 BPalpha的肝癌细胞系,HepG 2的组成型基因表达,显着增强治疗与单核细胞条件培养基,12-O-十四烷酰佛波醇-13-乙酸酯,白细胞介素-6和肿瘤坏死因子,但不是由钙离子载体或白细胞介素-1 β。4.血清C4 BP水平测定各种自身免疫性疾病患者血清C4 BP水平。活动性或LAC阳性的SLE、Behcet病、前列腺炎、PSS、RA和MCTD患者C4 BP水平显著升高。C4 BP水平与CRP、C3、CH 50相关。
英文摘要
1. Purification of human C4-binding protein (C4BP) and development of antibody against the purified C4BP Human C4BPalpha was purified from 1.5L of plasma by multiple steps including BaC12 precipitation, Intralipid absorption, ultracentrifugation, ethanol/ethel extraction, column chromatographies (DE52,S400 and S300). Antibodies against this protein were raised in rabbits and mice. Monoclonal antibody (IgG) was also developed. 2. Human genomic C4BP gene Human genomic C4BPalpha gene was analyzed. This gene consists of 12 exons and spans about 40 kb. Each of the SCRs is encoded by a single exon, except for the second SCR (SCR II), which is encoded by two separate exons. The 5' flanking region was sequenced up to 380 bases upstream from the putative transcription initiation site. Several possible binding sites for transcription factors were identified. 3. Gene expression of the C4BPalpha The gene expression of the C4BP alpha in normal liver cell and hepatoma lines was demonstrated. The constitutive gene expression of C4BPalpha by a hepatoma line, HepG2, was significantly augmented by treatment with monocyte conditioned medium, 12-O-tetradecanoylphorbol-13-acetate,interleukin-6 and tumor necrosis factor but not by a calcium ionophore or interleukin-1beta. 4. Serum levels of C4BP Serum levels of C4BP were measured in patients with various autoimmune disease. Significantly high level of C4BP was observed in patients with active or LAC-positive SLE,Behcet disease, aortitis, PSS,RA and MCTD. The level of C4BP was correlated with CRP, C3 and CH50.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Shimoda Kazuya: "Identification of a functional receptor for granulocyte colony-stimulating factor on platelets." Journal of Clinical Investigation.
Shimoda Kazuya:“鉴定血小板上粒细胞集落刺激因子的功能受体。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Okamura Seiichi: "The effects of recombinant human granulocyte-macrophage colony-stimulating factor on-the induction of lymphokineactivated killer cells in vitro." International Journal of Immunopharmacology. 13. 587-593 (1991)
冈村精一:“重组人粒细胞-巨噬细胞集落刺激因子对体外诱导淋巴因子激活的杀伤细胞的影响。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Okamura Seiichi: "A traditional chinese herbal medicine,renーshenーyangーtang(Japanese name:ninjinーyoeiーto)augments the production of granulocyteーmacrophage colonystimulating factor from human peripheral blood mononuclear cells in vitro." International Journ
Seiichi Okamura:“一种传统中草药,任神阳汤(日文名:ninjin-yoei-to)可在体外增强人外周血单核细胞产生粒细胞-巨噬细胞集落刺激因子。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shimoda Kazuya: "Granulocytecolony-stimulating factor receptors on human leukemia:Biphenotypic leukemic cells posesses G-CSF receptors." Cancer Research. 52. 3252-3255 (1992)
Shimoda Kazuya:“人类白血病的粒细胞集落刺激因子受体:双表型白血病细胞拥有 G-CSF 受体。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Aso Tejiro: "Genomic organization of the α chain of the human C4bーbinding protein." Biochemcal Biophysical Research Communication. 174. 222-227 (1991)
Aso Tejiro:“人类 C4b 结合蛋白 α 链的基因组组织。”174. 222-227 (1991)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
Studies on soluble granulocyte colony-stimulating factor (G-CSF) receptor
-
批准号:08671239
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:OKAMURA Seiichi
-
依托单位:
EXPRESSION OF MYELOID PHENOTYPES DURING HUMAN B-CELL DIFFERENTIATION : ANALYSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA
-
批准号:05670916
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1993
-
负责人:OKAMURA Seiichi
-
依托单位:
海外基金